Aytu Biopharma (AYTU) Share-based Compensation (2014 - 2026)
Aytu Biopharma (AYTU) posted quarterly Share-based Compensation of $148000.0 for Q1 2026, down 47.7% quarter-over-quarter from $283000.0 in Q4 2025.
Aytu Biopharma (AYTU) Share-based Compensation (2014 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Share-based Compensation for 13 consecutive years, with $148000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation changed N/A year-over-year to $148000.0; the TTM figure through Mar 2026 stood at $658000.0 (down 2.66% YoY), while the FY2025 annual figure was $576000.0, down 80.23% from the prior year.
- Share-based Compensation fell to $148000.0 in Q1 2026 per AYTU's latest filing, from $283000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.1 million in Q4 2022 and bottomed at $113000.0 in Q2 2025.
- Historically, Share-based Compensation has averaged $777562.5 across 5 years, with a median of $815500.0 in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation jumped 149.55% — and 2024, when it plunged 81.59%.
- Aytu Biopharma's Share-based Compensation stood at $3.1 million in 2022, then plunged by 73.26% to $820000.0 in 2023, then slumped by 81.59% to $151000.0 in 2024, then jumped by 87.42% to $283000.0 in 2025, then tumbled by 47.7% to $148000.0 in 2026.
- Business Quant data shows AYTU's Share-based Compensation at $148000.0 in Q1 2026, $283000.0 in Q4 2025, and $114000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn | 148,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,000.00 |
| Mar 31, 2026 | 148,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 811,000.00 |
| Mar 31, 2024 | 811,000.00 |
| Dec 31, 2023 | 820,000.00 |
| Dec 31, 2023 | 820,000.00 |
| Sep 30, 2023 | 930,000.00 |
| Sep 30, 2023 | 930,000.00 |